References
- Mol BWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet. 2016;387(10022):999–1011.
- Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010;5:173–192.
- Carpene C, Dray C, Attane C, et al. Expanding role for the apelin/APJ system in physiopathology. J PhysiolBiocbem.2007;63:359–373.
- Medhurst AD, Jennings CA, Robbins MJ, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenousligand apelin. J Neurochem. 2003;84(5):1162–1172.
- Hus-Citharel A, Bouby N, Frugiere A, et al. Effect of apelin on glomerular hemodynamic function in the rat kidney. Kidney Int. 2008;74(4):486–494.
- Gürlek B, Yılmaz A, Durakoğlugil ME, et al. J Evaluation of serum apelin-13 and apelin-36 concentrations in preeclamptic pregnancies. J Obstet Gynaecol Res. 2020;46(1):58–65.
- Liao YM, Qiao FY. Expression of apelin in placentas of patients with hypertensive disorders complicating pregnancy. Zhonghua Fu Chan Ke Za Zhi.2007;42:382–385.
- Bortoff KD, Qiu C, Runyon S, et al. Decreased maternal plasma apelin concentrations in preeclampsia pregnancy. Hypertens. 2012;31(4):398–404.
- Cobellis L, De Falco M, Mastrogiacomo A, et al. Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas. Histol Histopathol. 2007;22(1):1–8.
- National High Blood Pressure Education Program Working Group. Report on high blood pressure in pregnancy. National Institutes of Health Publication No. 00-3029.Washington DC: National Institutes of Health; 2000.
- Gathiram P, Moodley J. Pre-eclampsia: its pathogenesis and pathophysiolgy. Cardiovasc J Afr. 2016;27(2):71–78.
- Bartsch E, Medcalf KE, Park AL, et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;19:i1753.
- Szpera-Gozdziewicz A, Breborowicz GH. Endothelial dysfunction in the pathogenesis of pre-eclampsia. Front Biosci. 2014;19:734–746.
- Ueki N, Takeda S, Koya D, et al. The relevance of the renin-angiotensin system in the development of drugs to combat preeclampsia. Int J Endocrinol. 2015;2015:572713.
- August P, Lenz T, Ales KL, et al. Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol. 1990;163(5 Pt 1):1612–1621.
- LeeDK, ChengR, NguyenT, et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem. 2000;74(1):34–41.
- Liao YM, Qiao FY, FuZ, et al. Expression of Apelin in placentas of patients with hypertensive disorders complicating pregnancy. Zhonghua Fu Chan Ke Za Zhi. 2007;42(6):382–385.
- Yamaleyeva LM, Chappell MC, Brosnihan KB, AntonL, et al. Downregulation of apelin inthe human placental chorionic villi from preeclamptic pregnancies. Am J Physiol Endocrinol Metab. 2015;309(10):852–860.
- KaleaAZ, BatlleD. Apelin and ACE2 in cardiovascular disease. Curr Opin Investig Drugs. 2010;11(3):273–282.
- MerrillDC, KarolyM, ChenK, et al. Angiotensin-(1–7) in normal and preeclamptic pregnancy. ENDO. 2002;18(3):239–245.
- CharoDN, Ho M, Fajardo G, et al. Endogenous regulation of cardiovascular function by apelin-APJ. Am J Physiol Heart Circ Physiol.2009;297:1904–1913.
- Cox CM1, D'AgostinoSL, Miller MK, et al. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol. 2006;296(1):177–189.
- Charles CJ. Putative role for apelin in pressure/volume homeostasis and cardiovascular disease. Cardiovasc Hematol Agents Med Chem. 2007;5(1):1–10.
- Kidoya H, Takakura N. Biology of the apelin-APJ axis in vascular formation. J Biochem. 2012;152(2):125–131.
- Leeper NJ, Tedesco MM, Kojima Y, et al. Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. Am J Physiol Heart Circ Physiol.2009;296:1329–1335.
- Kucur M, Tuten A, Oncul M, et al. Maternal serum apelin and YKL-40 levels in early and late-onset pre-eclampsia. Hypertens Pregnancy. 2014;33(4):467–475.
- Simsek Y, Celik O, Yilmaz E, et al. Ozer ASerum levels of apelin, salusin alpha and salusin-beta in normal pregnancy and preeclampsia. J Matern Fetal Neonatal Med. 2012;25(9):1705–1708.
- Yamaleyeva LM, Brosnihan KB, Elsangeedy E, et al. Systemic outcomes of (Pyr1)-apelin-13 infusion at mid-late pregnancy in a rat model with preeclamptic features. Sci Rep. 2019;9(1):8579.